But vape oil contamination by synthetic cannabinoids is one possibility that has flown under the radar. Project CBD maintains that synthetic cannabinoids deserve serious attention. Synthetic cannabinoids may also be relevant in patients with acute eosinophilic pneumonia and anyone with concurrent neurological or cognitive impairment. No legal market in the United States requires testing to ensure the absence of synthetic cannabinoids in cannabis or CBD products. Despite these findings, reports about the current outbreak generally do not discuss synthetic cannabinoids.

Source: Wall Street Journal November 17, 2019 16:30 UTC